Literature DB >> 6147220

Pharmacokinetic drug interactions with theophylline.

J H Jonkman, R A Upton.   

Abstract

Since up to 90% of a theophylline dose is biotransformed, drugs influencing microsomal enzyme systems in the liver may affect the elimination of theophylline. Other integrated mechanisms (e.g. hepatic uptake) may also be altered by concurrent administration of other drugs. Whatever the mechanism, the interaction may be sufficient to necessitate adjustment of the theophylline dosage, preferably guided by plasma theophylline determinations. Comedication with phenobarbitone may require an increase of the theophylline dose by about 30% due to increased clearance resulting from enzyme induction. Similarly, with phenytoin and carbamazepine a dose increase of about 40 to 50% may be required. In the case of rifampicin, isoniazid or sulphinpyrazone comedication, an increase of the theophylline dose by about 20 to 25% may be needed. On the other hand, other drugs decrease theophylline clearance, making a reduction in the dose of concurrent theophylline advisable: with usual doses of erythromycin, propranolol and isoprenaline (isoproterenol), a reduction of about 25% is needed; with cimetidine and oral contraceptives by about 30% or more; and with triacetyloleandomycin (troleandomycin) by about 50%. In high doses, the xanthine oxidase inhibitor allopurinol can also retard theophylline elimination, and a reduction of the theophylline dose by about 20% may be advisable. Conflicting results have been reported on the influence of frusemide (furosemide) and influenza vaccines, while data regarding the effect of corticosteroids, benzodiazepines and verapamil on theophylline kinetics are not yet conclusive. Many drugs, however, appear not to significantly affect theophylline clearance. Some are from the same therapeutic group as the drugs mentioned above and offer clinical alternatives for coadministration with theophylline. Examples of drugs not found to have a significant effect on theophylline pharmacokinetics are ranitidine, josamycin, midecamycin, amoxycillin, tetracycline, cephalexin, cefaclor, orciprenaline, metoprolol, antacids, medroxyprogesterone acetate, metoclopramide and metronidazole. Most of the drugs discussed in this review appear not to affect the volume of distribution of theophylline significantly.

Entities:  

Keywords:  Adrenal Cortex Hormones--pharmacodynamics; Antibiotics--pharmacodynamics; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods; Drugs--pharmacodynamics; Endocrine System; Family Planning; Hormones; Oral Contraceptives; Physiology; Pulmonary Effects; Reproductive Control Agents; Treatment

Mesh:

Substances:

Year:  1984        PMID: 6147220     DOI: 10.2165/00003088-198409040-00002

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  116 in total

1.  Effect of smoking on theophylline disposition.

Authors:  S N Hunt; W J Jusko; A M Yurchak
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

2.  Theophylline-furosemide inactivation?

Authors:  J W Toback; M E Gilman
Journal:  Pediatrics       Date:  1983-01       Impact factor: 7.124

3.  Effect of secobarbital on theophylline clearance.

Authors:  J A Paladino; N A Blumer; R R Maddox
Journal:  Ther Drug Monit       Date:  1983       Impact factor: 3.681

4.  Influence of trivalent influenza vaccine on serum theophylline levels.

Authors:  R G Fischer; B H Booth; D Q Mitchell; A H Kibbe
Journal:  Can Med Assoc J       Date:  1982-06-01       Impact factor: 8.262

5.  Decreased clearance of theophylline due to cimetidine.

Authors:  M M Weinberger; G Smith; G Milavetz; L Hendeles
Journal:  N Engl J Med       Date:  1981-03-12       Impact factor: 91.245

6.  Cimetidine-theophylline interaction: report of four patients.

Authors:  J H Bauman; B J Kimelblatt; T R Caraccio; H M Silverman; G I Simon; G J Beck
Journal:  Ann Allergy       Date:  1982-02

7.  Nonlinear theophylline elimination.

Authors:  D D Tang-Liu; R L Williams; S Riegelman
Journal:  Clin Pharmacol Ther       Date:  1982-03       Impact factor: 6.875

8.  Effect of erythromycin stearate on serum theophylline concentration in patients with chronic obstructive lung disease.

Authors:  B M Stults; J Felice-Johnson; M D Higbee; K Hardigan
Journal:  South Med J       Date:  1983-06       Impact factor: 0.954

9.  Pharmacokinetics of theophylline in hepatic disease.

Authors:  A Mangione; T E Imhoff; R V Lee; L Y Shum; W J Jusko
Journal:  Chest       Date:  1978-05       Impact factor: 9.410

10.  Inhibition of theophylline metabolism by long-term allopurinol administration.

Authors:  R L Manfredi; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1981-02       Impact factor: 6.875

View more
  43 in total

1.  Stereoselective pharmacokinetics of oral nitrendipine in elderly hypertensive patients with normal and impaired renal function.

Authors:  P A Soons; T Ankermann; D D Breimer; W Kirch
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics.

Authors:  B Bruguerolle; M Toumi; F Faraj; D Vervloet; H Razzouk
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 3.  Formulary management of macrolide antibiotics.

Authors:  D R Guay
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

4.  Effect of oral contraceptive steroids on the pharmacokinetics of phenprocoumon.

Authors:  H Mönig; C Baese; H T Heidemann; E E Ohnhaus; H M Schulte
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

Review 5.  Treatment of concomitant illnesses in patients receiving anticonvulsants: drug interactions of clinical significance.

Authors:  P Loiseau
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

6.  Lack of an effect of nefazodone on the pharmacokinetics and pharmacodynamics of theophylline during concurrent administration in patients with chronic obstructive pulmonary disease.

Authors:  R C Dockens; D Rapoport; D Roberts; D S Greene; R H Barbhaiya
Journal:  Br J Clin Pharmacol       Date:  1995-12       Impact factor: 4.335

7.  Theophylline pharmacokinetics after intravenous infusion with ethylenediamine or sodium glycinate.

Authors:  J Caldwell; A H Staib; I A Cotgreave; M Siebert-Weigel
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

8.  The interaction of erythromycin with theophylline.

Authors:  O Paulsen; P Höglund; L G Nilsson; H I Bengtsson
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

9.  Lack of effect of amoxicillin on theophylline pharmacokinetics.

Authors:  J H Jonkman; W J van der Boon; R Schoenmaker; A Holtkamp; J Hempenius
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335

10.  Effects of lansoprazole on pharmacokinetics and metabolism of theophylline.

Authors:  T Kokufu; N Ihara; N Sugioka; H Koyama; T Ohta; S Mori; K Nakajima
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.